HEALTH. ILLUMINATED. Trademark

Trademark Overview

On Friday, January 17, 2025, a trademark application was filed for HEALTH. ILLUMINATED. with the United States Patent and Trademark Office. The USPTO has given the HEALTH. ILLUMINATED. trademark a serial number of 99009577. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, October 28, 2025. This trademark is owned by Shine Technologies, LLC. The HEALTH. ILLUMINATED. trademark is filed in the Pharmaceutical Products category with the following description:

Active pharmaceutical ingredients, namely, lutetium-177, for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely, non-carrier added lutetium-177 for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; active pharmaceutical ingredients, namely, terbium-149, terbium-152, terbium-155, or terbium-161 for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely, actinium-225 for therapeutic or diagnostic use; parent radioisotopes for the preparation of active pharmaceutical ingredients, namely, molybdenum-99 for therapeutic or diagnostic use
health. illuminated.

General Information

Serial Number99009577
Word MarkHEALTH. ILLUMINATED.
Filing DateFriday, January 17, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, October 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesActive pharmaceutical ingredients, namely, lutetium-177, for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely, non-carrier added lutetium-177 for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; active pharmaceutical ingredients, namely, terbium-149, terbium-152, terbium-155, or terbium-161 for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely, actinium-225 for therapeutic or diagnostic use; parent radioisotopes for the preparation of active pharmaceutical ingredients, namely, molybdenum-99 for therapeutic or diagnostic use
NOT AVAILABLEHEALTH

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShine Technologies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJanesville, WI 53546

Trademark Events

Event DateEvent Description
Friday, January 17, 2025NEW APPLICATION ENTERED
Monday, June 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 28, 2025ASSIGNED TO EXAMINER
Monday, July 28, 2025NON-FINAL ACTION WRITTEN
Monday, July 28, 2025NON-FINAL ACTION E-MAILED
Monday, July 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

illuminated health pharmaceutical active namely ingredients diagnostic therapeutic terbium medical oncological diseases